Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Albie / Re: I'd consider selling MMP if USPTO re-validates

Hey now, don't sugar coat your opposition to my post! lolol!


Based on your comment about sacrificing "hundreds of billions over the next 5 years", I would be in total agreement with you. However, I haven't expected that kind of windfall, and I doubt TPL or PTSC has. However, IF they do expect that with a revalidated MMP, they should have and should be, IMO, communicating that in some fashion to the market, as it has never been expressed as far as I know, and it would do wonders for the PPS, I believe.

As for control, my post was directed to a scenario AFTER USPTO re-validation, not before that. So the control I was speaking to has to do with the licensing and litigating efforts of Alliacense/TPL and the board make up of PDS (2 to 1 in favor of TPL).

Nonetheless, I'll take your post as a "maybe!". lolol.

Share
New Message
Please login to post a reply